US rethinks timing of biotech crackdown, easing pressure on WuXi
美国制裁提供喘息期 “药明系”或转攻欧洲

The latest draft of a U.S. biosecurity law would give drug companies until 2032 to cut their ties with Chinese contract suppliers, allowing WuXi companies time to focus on Europe instead.
美国参众两院最新《生物安全法案》草案暂定以2032年作为脱钩最后期限，为“药明系”的紧张局面带来缓和空间。